| Health / Medical Topics |
Volitinib
An orally bioavailable inhibitor of the c-Met receptor tyrosine kinase with potential antineoplastic activity. Volitinib selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. This may result in cell growth inhibition in tumors that overexpress the c-Met protein. C-Met encodes the hepatocyte growth factor receptor tyrosine kinase and plays an important role in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis; this protein is overexpressed or mutated in a variety of cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A volcano is a vent in the Earth's crust. Hot rock, steam, poisonous gases, and ash reach the Earth's surface when a…
A dihydropteridinone Polo-like kinase 1 (Plk1) inhibitor with potential antineoplastic activity. Volasertib selectively inhibits Plk1, inducing selective G2/M arrest followed by apoptosis…
A question about an individual's voice or speech difficulties at its worst.
A question about whether an individual's voice has or had the usual quality and strength.
A self-assessment to evaluate the perceived psychosocial consequences of a patient's voice disorder in terms of emotional, physical, and functional factors. …
Voice is the sound made by air passing from your lungs through your larynx, or voice box. In your larynx are your…
